ADGM RA Publishes Consultation Paper on Proposed Amendments to Cell Companies Framework
The ADGM RA has issued a Consultation Paper seeking public feedback on proposed amendments to Part 36 of the Companies Regulations 2020 (the “Companies Regulations”) and the proposed Companies Regulations (Cell Companies) Rules 2026 (the “Cell Companies Rules”).
ADGM’s Registration Authority has opened Consultation Paper No. 10 of 2026 on restructuring the cell companies framework in Part 36 of the Companies Regulations 2020 and introducing standalone Companies Regulations (Cell Companies) Rules 2026. The proposal is primarily a framework and administration reform rather than a change to the core liability segregation model: substantive rights, liabilities and protections would remain in Part 36, while operational requirements would move into dedicated rules.
Key dates
- 2026-11-17
- The consultation opened and Consultation Paper No. 10 of 2026 was published.
- 2026-12-10 Deadline
- Deadline for submitting consultation responses through the ADGM Registration Authority consultation portal.
Suggested considerations
- Compliance teams and advisers may wish to review Consultation Paper No. 10 of 2026 together with the proposed Part 36 amendments and the draft Cell Companies Rules, rather than relying only on the announcement summary.
- Affected firms should consider submitting comments through the ADGM Registration Authority consultation portal by 10 December 2026; the consultation materials state that comments sent to the portal-related email address may not be considered as consultation submissions.
- Existing cell companies may wish to map current processes for cell creation and registration, statutory registers, confirmation statements, accounting records, accounts, filings, naming and changes of status against the proposed standalone requirements.
- Incorporated cell companies should consider assessing whether the proposed registered-office changes could simplify their corporate administration, while identifying consequential updates needed for notices, statutory records, contracts, service-provider instructions and internal governance procedures.
- Fund, insurance, asset-holding and family office groups may wish to assess whether the clearer administrative architecture affects the attractiveness, cost or operational design of proposed cell structures, without assuming that the consultation changes existing regulatory approval or notification requirements.
- Firms should continue operating under the current Companies Regulations 2020 and applicable FSRA requirements until the final amendments, final Cell Companies Rules and related guidance are published.
What changed
The proposal would amend Part 36 to retain the substantive corporate-law provisions governing protected cell companies, incorporated cell companies and their cells, while adding a rule-making power for the Registrar covering administration, operation and establishment procedures. The proposed Cell Companies Rules would contain operational and administrative provisions concerning creation and registration of cells, registers, confirmation statements, accounting records, accounts, filings, names and changes of status.
Compliance impact
The immediate compliance impact is limited because this is a consultation and does not introduce operative obligations. If enacted, firms are likely to face process and documentation changes around cell establishment, registration, statutory records, accounts, filings, names, status changes and registered-office arrangements, but the regulator proposes to preserve the existing substantive allocation of rights, liabilities and protections.
References
- [1] raconsultations.adgm.com/consultation/consultation-paper-...
- [2] adgm.com/media/announcements/adgm-ra-publishes-consultati...
- [3] adgm.com/legal-framework/public-consultations
- [4] raconsultations.adgm.com/browse
- [5] en.adgm.thomsonreuters.com/rulebook/consultation-paper-no... third-party
- [6] adgm.com/registration-authority
- [7] adgm.com/adgm-courts/judgments
- [8] en.adgm.thomsonreuters.com/entiresection/9683 third-party
AI-generated analysis. May contain errors or omissions — verify with the original ADGM source before acting. Full disclaimer.